Overcoming treatment resistance in depression.
Treatment-resistant depression is commonly encountered by mental health professionals. Strategies for the treatment of resistant depression, including augmentation strategies and switching antidepressants, are reviewed. The potential advantages and disadvantages of each of these strategies are discussed.
Nelson
J C
JC
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn 06520-8037, USA.
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002065:Buspirone / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome; D014284:Triiodothyronine / Q000627:therapeutic use
D000928:Antidepressive Agents; D002065:Buspirone; D008094:Lithium; D010869:Pindolol; D017367:Selective Serotonin Reuptake Inhibitors; D014284:Triiodothyronine